During the past decade, Affiliated Hospital of Guangdong Medical University conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 1 clinical trials were completed, i.e. on average, 3.3% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 1 clinical trials were completed. i.e. 4.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Affiliated Hospital of Guangdong Medical University" #1 sponsor was "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 8 trials, followed by "Pfizer" with 3 trials sponsored, "Sun Yat-sen University" with 3 trials sponsored, "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 2 trials sponsored and "The First Affiliated Hospital of Guangzhou Medical University" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Affiliated Hospital of Guangdong Medical University" #1 collaborator was "Affiliated Hospital of Guangdong Medical University" with 2 trials as a collaborator, "Nanfang Hospital of Southern Medical University" with 2 trials as a collaborator, "Amylin Pharmaceuticals, LLC." with 1 trials as a collaborator, "Beijing Anzhen Hospital" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Affiliated Hospital of Guangdong Medical University" are "Nasopharyngeal Carcinoma" (3 trials), "Airway Responsiveness" (2 trials), "Asthma" (2 trials), "Chest Syndrome" (2 trials) and "Clinical Anxiety" (2 trials). Many other conditions were trialed in "Affiliated Hospital of Guangdong Medical University" in a lesser frequency.

Most popular intervention types in "Affiliated Hospital of Guangdong Medical University" are "Drug" (33 trials), "Procedure" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "AK105 injection" (2 trials), "Anlotinib" (2 trials), "Anlotinib hydrochloride capsule" (2 trials) and "TQB2450" (2 trials). Other intervention names were less common.

The vast majority of trials in "Affiliated Hospital of Guangdong Medical University" are 33 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Affiliated Hospital of Guangdong Medical University". 3 are not yet recruiting, 15 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Affiliated Hospital of Guangdong Medical University, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Affiliated Hospital of Guangdong Medical University, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 3 trials that are defined as “Not Applicable".